Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETA-UC-J budesonide extended-release study in mild to moderate ulcerative colitis
jRCTs031250131Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of budesonide in autoimmune colitis, sponsored by Mochida Pharmaceutical Co., Ltd. Primary endpoint: Rate of symptomatic remission at final assessment. Started Jun 2025; status: completed.
02
Drugs
budesonide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCTs031250131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250131.